Cargando…
Practical recommendations for implementing a Bayesian adaptive phase I design during a pandemic
BACKGROUND: Modern designs for dose-finding studies (e.g., model-based designs such as continual reassessment method) have been shown to substantially improve the ability to determine a suitable dose for efficacy testing when compared to traditional designs such as the 3 + 3 design. However, impleme...
Autores principales: | Ewings, Sean, Saunders, Geoff, Jaki, Thomas, Mozgunov, Pavel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771176/ https://www.ncbi.nlm.nih.gov/pubmed/35057758 http://dx.doi.org/10.1186/s12874-022-01512-0 |
Ejemplares similares
-
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
por: Mozgunov, Pavel, et al.
Publicado: (2019) -
An information theoretic phase I–II design for molecularly targeted agents that does not require an assumption of monotonicity
por: Mozgunov, Pavel, et al.
Publicado: (2018) -
Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial
por: Mozgunov, Pavel, et al.
Publicado: (2022) -
Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs
por: Burnett, Thomas, et al.
Publicado: (2020) -
Loss functions in restricted parameter spaces and their Bayesian applications
por: Mozgunov, P., et al.
Publicado: (2019)